Transfusion-Transmissible Infections Monitoring System (TTIMS) 75F40125Q00337
Summary
AI-generated · Aug 24, 2025TTIMS services are required to support FDA's Center for Biologics Evaluation and Research. Review the attached solicitation and documents and follow the instructions to submit an offer. Offerors must be able to successfully execute all tasks and deliverables specified in the solicitation.
Record 1 and Record 2 describe the same TTIMS requirement; there are no changes or new information between notices.
The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection Monitoring System (TTIMS) services. Please review the attached solicitation and other documents. If interested, please follow the instructions written in the solicitation. Offerors must be able to successfully execute all of the tasks and deliverables of this requirement.
From Solicitation posted on Aug 01, 2025The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection Monitoring System (TTIMS) services. Please review the attached solicitation and other documents. If interested, please follow the instructions written in the solicitation. Offerors must be able to successfully execute all of the tasks and deliverables of this requirement.
From Solicitation posted on Aug 13, 2025This award is fixed-priced and was competitive.
From Award Notice posted on Sep 08, 2025Notice history
3-
-
Solicitation Posted Aug 13, 2025No changes from previous notice
-
Award Notice LATEST Posted Sep 08, 2025
Details
Award Information
Award Notices
Posted: Sep 08, 2025
This award is fixed-priced and was competitive.
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| VITALANT | GKT4L2JZJ622 | 42091 | Scottsdale, AZ |
Contacts
Agency
Place of Performance
USA